Abstract
First-Line Camrelizumab versus Placebo Plus Chemotherapy with or without Radiotherapy for Brain Metastases in Non-Small-Cell Lung Cancer: The CTONG 2003 Randomized Placebo-Controlled Trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have